9 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
management in Pulmonary ... Hypertension (PAH ... #Hypertension #PAH ... #Management #Algorithm ... #treatment #pharmacology
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Intermediate Risk Pulmonary ... Hypertension (PAH ... ) Management Algorithm ... #Hypertension #PAH ... #treatment #pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... corticosteroid; FEV1: forced ... #Management #Pulmonary
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... or been newly diagnosed ... following initial diagnosis ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... Obstructive Pulmonary ... assessment test; FEV1, forced ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... & Dry) is the treatment ... #algorithm #management ... #table #foamed ... icu #clinical #pharmacology
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... pneumonia, ARDS, DAH ... of lipid-laden 'foamy ... • Presence of foamy ... macrophages Treatment
The crusade against “Ab”Normal Saline continues.  This is a non-physiologic fluid that can harm our
against the drop in pH ... #foamed #criticalcare ... #management #diagnosis ... #treatment #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... amyloidosis, PAH ... Adenocarcinoma Treatment ... lubricants • Pharmacologic